A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT00700427-74136 (Clinical Trial 227935)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy227935.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Tulsa |
|
State:
|
|
OK |
| Zip Code: |
|
74136 |
| Conditions: |
|
Attention Deficit Hyperactivity Disorder |
| Purpose: |
|
LYDO is a multi-center study that will enroll approximately 1925 adult outpatients with
Attention Deficit/Hyperactivity Disorder (ADHD). Patients will receive under open label
conditions atomoxetine up to 100 mg/day during the acute, open label part of the study.
Those patients that meet the response criteria will continue the blind phase of the study up
to a year. During that period patients that respond to atomoxetine will be randomized to
continue the treatment with atomoxetine or with placebo (neither the patients or
investigators know if patients receive atomoxetine or placebo).
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Adults
- Male or female
- Must meet ADHD according to Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition Text Revision™ (DSM-IV-TR™) criteria
Exclusion Criteria:
- Comorbidity with major psychiatric disorder
- Clinically significant depression or anxiety
- Patients with significant medical conditions
- Current alcohol/drugs abuse/dependence
- Concomitant excluded medications |
|
|
|
| Study is available at: |
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tulsa, OK 74136
United States
Primary Contact:
There may be multiple sites in the clinical trial 1-877-CTLILLY (1-877-285-4559), or
Phone: 1-317-615-4559 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|